Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gastric Hypoplasia in mice lacking Fibroblast Growth Factor 9

ABSTRACT: Gastric Hypoplasia in mice lacking Fibroblast Growth Factor 9

PROVIDER: PRJNA1182396 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR31236067_1.fastq.gz	Fastqsanger.gz
	SRR31236067_2.fastq.gz	Fastqsanger.gz
	SRR31236068_1.fastq.gz	Fastqsanger.gz
	SRR31236068_2.fastq.gz	Fastqsanger.gz
	SRR31236069_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Gastric Hypoplasia in mice lacking Fibroblast Growth Factor 9

Project description:To determine the role of Fgf9 in gastric development, we collected E15.5 Fgf9 KO (Fgf9LacZ/LacZ) and Het (Fgf9LacZ/+) stomachs for RNA-seq analysis. 3 stomachs were pooled for each RNA-seq sample.

2024-11-15 | GSE281156 | GEO

Twist1 knockdown in two gastric cancer-associated fibroblast lines

Project description:Primary human gastric cancer-associated fibroblast (CAF) cultures (CAF14 and CAF32) were establised from 2 gastrectomy specimens. Silencing the expression (loss-of-function effect) of Twist1 in CAFs showed candidate target genes regulated by Twist1 and abrogated their tumor-promoting properties. Experiment design: two gastric CAFs (CAF14 adn CAF32, respectively) were establised from two gastric cancer patients and Twist1 knockdown studies were performed using shRNA.

2014-10-28 | E-GEOD-62738 | biostudies-arrayexpress

Twist1 gain-of-function studied in 2 normal gastric fibroblast lines

Project description:Primary human gastric normal fibroblast cultures (NL14 and NL32, repectivley) were establised from 2 gastrectomy specimens. Enforced expression (gain-of-function effect) of Twist1 in 2 gastric normal fibroblasts (NL14 and NL32) showed candidate target genes and CAF markers upregulated by Twist1. Experiment design: 2 normal gastric fibroblasts (NL14 and NL32) were establised and studied for Twist1 gain-of-function.

2014-10-28 | E-GEOD-62739 | biostudies-arrayexpress

Twist1 gain-of-function studied in 2 normal gastric fibroblast lines

2014-10-28 | GSE62739 | GEO

Twist1 knockdown in two gastric cancer-associated fibroblast lines

2014-10-28 | GSE62738 | GEO

Transcriptome analysis of mouse embrynic fibroblast cells lacking multiple core clock genes

Project description:Transcriptome analysis of mouse embrynic fibroblast cells lacking multiple core clock genes

| PRJNA663470 | ENA

Molecular Characterization of Pontocerebellar Hypoplasia

Project description:Molecular Characterization of Pontocerebellar Hypoplasia

| PRJNA1062912 | ENA

Molecular Characterization of Pontocerebellar Hypoplasia

Project description:Molecular Characterization of Pontocerebellar Hypoplasia

| PRJNA1062911 | ENA

RNA-seq of control and CHH (cartilage-hair hypoplasia) fibroblasts transdifferentiated into chondrocytes-like cells

Project description:We used primary human CHH (cartilage-hair hypoplasia) and control fibroblasts in a chondrogenic transdifferentiation model (FDC; fibroblast-derived chondrocytes) to determine the chondrogenic capacity and differential pathway regulation of CHH cells. For the sequencing experiment, dermal fibroblasts from control donors (n=4) and CHH patients (n=4) were isolated from skin biopsies, plated at high density into wells coated with aggrecan, and cultured for three days in an FDC transdifferentiation medium. Total RNA was isolated at three different time points (Day 0, 1, and 3; in total 24 RNA samples), and sequenced using the NextSeq platform (Illumina).

2021-10-09 | E-MTAB-10996 | biostudies-arrayexpress

Fibroblast growth factor receptor signaling as therapeutic targets in gastric cancer.

Project description:Fibroblast growth factor receptors (FGFRs) regulate a variety of cellular functions, from embryogenesis to adult tissue homeostasis. FGFR signaling also plays significant roles in the proliferation, invasion, and survival of several types of tumor cells. FGFR-induced alterations, including gene amplification, chromosomal translocation, and mutations, have been shown to be associated with the tumor initiation and progression of gastric cancer, especially in diffuse-type cancers. Therefore, the FGFR signaling pathway might be one of the therapeutic targets in gastric cancer. This review aims to provide an overview of the role of FGFR signaling in tumorigenesis, tumor progression, proliferation, and chemoresistance. We also discuss the accumulating evidence that demonstrates the effectiveness of using clinical therapeutic agents to inhibit FGFR signaling for the treatment of gastric cancer.

| S-EPMC4768188 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data